2 ms·
Limiting rollouts/updates velocity would probably be a good idea too. We don’t let drug companies sell their products to everyone the second it’s produced. Fir
by Scoundreller 8y ago
Limiting rollouts/updates velocity would probably be a good idea too.
We don’t let drug companies sell their products to everyone the second it’s produced. First you test in mice, then 10 people, then 100, then 1000, then, and only then, can you release it to an entire population (roughly speaking).